Find out why the results may temper claims that recursive self-improvement is on the horizon. —Michelle Kim This summer has ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
People don't like talkingabout their finances. I've been with my husband for 11 years, and I still give him the side-eye when he asks how much is in my savings account. For many people,it's ...
Nearly one in five U.S. adults have turned to AI for financial guidance. Almost none of them trust the answer. The research surveyed 5,075 adults in the U.S. and 2,117 in Canada. David Chubak, head of ...
Jeff Dean, one of the longest-serving and most influential executives at Google, is stepping down from the search giant to launch his own AI startup. Coming with him as co-founders are several other ...
Recursion Pharmaceuticals Inc. has disclosed IND clearance for REC-7735, its AI-designed PI3Kα H1047R inhibitor, in its quarterly earnings report. A phase I/II trial for patients with select PIK3CA ...
Google DeepMind’s strategy chief says the industry’s trillion-dollar AI buildout is a bet on recursive self-improvement: AI that makes better AI. He also admits today’s revenue cannot justify the ...
A horned, seven-foot machine wielding a chainsaw went viral across social media last week, drawing comparisons to mythological demons, video game bosses, and the Terminator. The California startup ...
Af­ter 37 years, Frank Ben­nett is re­tir­ing from Io­n­is Phar­ma­ceu­ti­cals. Ben­nett start­ed at Io­n­is as a found­ing sci­en­tist in 1989 and climbed to the role of CSO. Ben­nett will re­tire in ...
BTS will not submit music for consideration at next year’s Grammy Awards, members of the K-pop supergroup announced Wednesday, a little over a month after the Recording Academy confirmed that the 2027 ...
In a decade of lead­ing and build­ing Re­cur­sion Phar­ma­ceu­ti­cals, Chris Gib­son at­tempt­ed to bridge the worlds of bi­ol­o­gy and tech­nol­o­gy. Now, months af­ter leav­ing Re­cur­sion, he’s ...